🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A surveillance of respiratory tract related adverse events in patients trea...
Status
Completed
Location
Cardiovascular Associates, P.C.
Start Date
2010-12
Trial ID
NCT01266265
The endothelin receptor antagonist macitentan showed significant improvemen...
Status
Terminated
Location
Fukuoka University Nishijin Hospital
Start Date
2019-01-08
Trial ID
NCT03809650
Treatments Being Tested
The Opsumit Users registry (OPUS; NCT02126943) was developed to characteriz...
Status
Completed
Location
Pulmonary Associates
Start Date
2017-08-03
Trial ID
NCT03197688
Treatments Being Tested
The purpose of this study is to learn more about the safety and effects of ...
Status
Terminated
Location
Ochsner Medical Center
Start Date
2016-06
Trial ID
NCT02885012
Treatments Being Tested
The purpose of this study is to demonstrate bioequivalence on the primary p...
Status
Completed
Location
PRAHS
Start Date
2022-02-04
Trial ID
NCT05236231
Treatments Being Tested
The purpose of this study is to assess the rate and extent of absorption of...
Status
Completed
Location
Clinical Pharmacology Unit
Start Date
2021-04-30
Trial ID
NCT04540744
Treatments Being Tested
The primary objective of this study is to demonstrate that macitentan and t...
Status
Completed
Location
CRS Clinical Research Services Mannheim
Start Date
2017-08-07
Trial ID
NCT03215966
Treatments Being Tested
Prospective observational drug registry developed to characterize the safet...
Status
Completed
Location
Investigator Site
Start Date
2014-04-30
Trial ID
NCT02126943
Treatments Being Tested